Cargando…

Socioeconomic Factors and Survival of Multiple Myeloma Patients

SIMPLE SUMMARY: Multiple Myeloma is the third most common hematologic malignancy. Outcomes have improved significantly, as the result of the introduction of novel agents as well as higher utilization of autologous Hematopoietic Cell Transplant. These complex treatment regimens are quite expensive an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chamoun, Kamal, Firoozmand, Amin, Caimi, Paolo, Fu, Pingfu, Cao, Shufen, Otegbeye, Folashade, Metheny, Leland, Patel, Seema, Gerson, Stanton L., Boughan, Kirsten, De Lima, Marcos, Malek, Ehsan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913279/ https://www.ncbi.nlm.nih.gov/pubmed/33546206 http://dx.doi.org/10.3390/cancers13040590

Ejemplares similares

Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens
por: Wang, Jiasheng, et al.
Publicado: (2023)

Cord Blood Transplantation: Can We Make it Better?
por: Metheny, Leland, et al.
Publicado: (2013)

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma
por: Caimi, Paolo F., et al.
Publicado: (2021)

Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria
por: Ahmed, Nausheen, et al.
Publicado: (2021)

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial
por: Malek, Ehsan, et al.
Publicado: (2023)

Understanding population-wide haplotype frequencies of human leukocyte antigen (HLA) alleles in linkage disequilibrium is important for hematopoietic stem cell transplantation()
por: Otegbeye, Folashade
Publicado: (2017)

Perioperative Management of Sickle Cell Disease
por: Adjepong, Kwame Ofori, et al.
Publicado: (2018)

Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
por: Otegbeye, Folashade, et al.
Publicado: (2018)

Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
por: Otegbeye, Folashade, et al.
Publicado: (2018)

Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies
por: Caimi, Paolo F., et al.
Publicado: (2017)

Allograft for Myeloma: Examining Pieces of the Jigsaw Puzzle
por: Malek, Ehsan, et al.
Publicado: (2017)

Vactosertib, a novel TGF-β1 type I receptor kinase inhibitor, improves T-cell fitness: a single-arm, phase 1b trial in relapsed/refractory multiple myeloma
por: Malek, Ehsan, et al.
Publicado: (2023)

Influence of gut microbiome on multiple myeloma: friend or foe?
por: Ahmed, Nausheen, et al.
Publicado: (2020)

Machine Learning to Predict Risk of Relapse Using Cytologic Image Markers in Patients With Acute Myeloid Leukemia Posthematopoietic Cell Transplantation
por: Arabyarmohammadi, Sara, et al.
Publicado: (2022)

Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience
por: Massoud, Mira Romany, et al.
Publicado: (2016)

Umbilical cord blood derived cellular therapy: advances in clinical development
por: Wang, Jiasheng, et al.
Publicado: (2023)

Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed–Platinum–Radiation in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer: Results of a Phase I Trial
por: Biswas, Tithi, et al.
Publicado: (2022)

Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal Cells
por: Metheny, Leland, et al.
Publicado: (2016)

A case of neurocognitive deficit strongly related to dasatinib therapy
por: Chamoun, Kamal, et al.
Publicado: (2020)

Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic Status
por: Mirsky, Matthew M, et al.
Publicado: (2023)

Predicting Successful Phase Advancement and Regulatory Approval in Multiple Myeloma From Phase I Overall Response Rates
por: Malek, Ehsan, et al.
Publicado: (2017)

Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
por: Ojo, Evelyn O., et al.
Publicado: (2019)

Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV
por: Qing, Yulan, et al.
Publicado: (2023)

Refractory inflammatory myopathy in hematopoietic stem cell transplant patients with chronic graft-versus-host disease: report of two cases
por: Golec, Sophia, et al.
Publicado: (2019)

Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?
por: Caimi, Paolo F., et al.
Publicado: (2014)

High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations
por: Carlisi, Melania, et al.
Publicado: (2022)

Identification of Long Non-Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors
por: Malek, Ehsan, et al.
Publicado: (2016)

High throughput chemical library screening identifies a novel p110-δ inhibitor that potentiates the anti-myeloma effect of bortezomib
por: Malek, Ehsan, et al.
Publicado: (2016)

Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma
por: Swamydas, Muthulekha, et al.
Publicado: (2022)

Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients
por: Maschan, Michael, et al.
Publicado: (2021)

PB2091: DISPARITIES IN ENROLMENT INTO MULTIPLE MYELOMA CLINICAL TRIALS BY SOCIOECONOMIC DEPRIVATION
por: Sridhar, Amrutha, et al.
Publicado: (2023)

Timing Embryo Preservation for a Patient with High-Risk Newly Diagnosed Acute Myeloid Leukemia
por: Ye, Rebecca, et al.
Publicado: (2018)

Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020)

Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell Clones is Defined by the Promoter CpG Methylation Pattern Observed by High-Throughput Methylation Specific Sequencing
por: Kenyon, Jonathan, et al.
Publicado: (2016)

Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors
por: Carlisi, Melania, et al.
Publicado: (2023)

Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients
por: Obeng-Gyasi, Samilia, et al.
Publicado: (2022)

Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study
por: Buradagunta, Christopher Staffi, et al.
Publicado: (2022)

Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma
por: Abdel Malek, Mohamed A.Y., et al.
Publicado: (2014)

Posttransplant Intramuscular Injection of PLX-R18 Mesenchymal-Like Adherent Stromal Cells Improves Human Hematopoietic Engraftment in A Murine Transplant Model
por: Metheny, Leland, et al.
Publicado: (2018)

The role of DNA damage repair in aging of adult stem cells
por: Kenyon, Jonathan, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_f1fc86g5ahsrf539lv9u2q6hk9